Aclarion is a health information services business based in the US. Aclarion shares (ACON) are listed on the NASDAQ and all prices are listed in US Dollars. Aclarion employs 3 staff and has a trailing 12-month revenue of around $49,901.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.19 |
|---|---|
| 52-week range | $0.56 - $4.35 |
| 50-day moving average | $0.89 |
| 200-day moving average | $1.11 |
| Wall St. target price | $3.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-7.12 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.1925 from 2024-09-04
| 1 week (2024-08-29) | -11.25% |
|---|---|
| 1 month (2024-08-05) | -31.40% |
| 3 months (2024-06-05) | -34.41% |
| 6 months (2024-03-05) | -48.67% |
| 1 year (2023-09-05) | -58.60% |
|---|---|
| 2 years (2022-09-02) | -83.69% |
| 3 years (2021-09-01) | N/A |
| 5 years (2019-09-01) | N/A |
| Revenue TTM | $49,901 |
|---|---|
| Gross profit TTM | $-8,883 |
| Return on assets TTM | -108.06% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | $0.38 |
| Market Capitalization | $4.9 million |
TTM: trailing 12 months
We're not expecting Aclarion to pay a dividend over the next 12 months.
Aclarion, Inc. , a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
Advanced Micro Devices (AMD), Intel Corporation (INTC) and Qualcomm Inc (QCOM) are top stocks like Nvidia. See our full list here.
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
Compare pros, cons, research tools and reviews for these two trading platforms.
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.